Viewing Study NCT07128550


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-01-02 @ 10:39 AM
Study NCT ID: NCT07128550
Status: RECRUITING
Last Update Posted: 2025-11-12
First Post: 2025-08-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Sponsor: Vir Biotechnology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module